← Eichor
Study identifier: NCT01000883 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior

Condition: Breast Cancer  ·  Sponsor: UNC Lineberger Comprehensive Cancer Center

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from women with locally advanced or metastatic breast cancer

This description comes directly from the study's public registry record.

Talk to the study team

Adrianna Warner  ·  (919) 966-7847  ·  adrianna_warner@med.unc.edu

Erin Kelly  ·  (919) 966-0040  ·  erin_kelly@med.unc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel HillChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01000883